F ERβ Formulation sorafenib contained aberrant activation of PI3K/Akt pathway, stemnessF sorafenib contained aberrant activation
F ERβ Formulation sorafenib contained aberrant activation of PI3K/Akt pathway, stemnessF sorafenib contained aberrant...